Hi Dr. Potter!
I was wanting to get your opinion on the biggest differences between GSN and CGH beyond the fresh vs. frozen transfer stuff. Do you believe (in your most unbiased opinion :wink:) that one is better than the other?
Thanks!
Printable View
Hi Dr. Potter!
I was wanting to get your opinion on the biggest differences between GSN and CGH beyond the fresh vs. frozen transfer stuff. Do you believe (in your most unbiased opinion :wink:) that one is better than the other?
Thanks!
Nevermind, I got my answer today at my consult.
Sent from my iPhone using Tapatalk
I am glad that you were able to get your answer. I will briefly go over the differences here:
GSN is more reliable for day 3 biopsy; GSN is more reliable for the smaller chromosomes (21,22,y); GSN detects uniparental disomy where CGH does not (eg Prader-Willi); GSN uses parental DNA finger print and so confirms right sperm/right egg where CGH does not; GSN gives you information about the origin of the abnormality in the embryo (bad egg or bad sperm) where CGH does not; GSN gives you specific confidence calls for each chromosome in each cell in your particular assay rather than an implied confidence (eg 'this test is 95% accurate') Hopefully this helps.
Dr. P
It does help! Thank you!
I do have one more question though, in the literature I was reading that was sent to me regarding GSN it states that a day 5 biopsy has a 15% higher success rate than a day 3 biopsy. Do you see that in your clinic or is the Day 5 biopsy pretty new?
Thanks Dr. P!!
Just for your info, this is what the pamphlet states...
» For Day 3 blastomere biopsy with fresh transfer there is approximately
a 50% ongoing pregnancy rate with embryo transfer following
testing; this rate is closer to 60% in patients aged 35 and younger and
45% in patients aged 36 and older.
» For Day 5 trophectoderm biopsy with Frozen Embryo Transfer (FET)
there is approximately a 75% ongoing pregnancy rate with embryo
transfer. This rate appears to be slightly higher in patients 35 and
younger and slightly higher in patients aged 36 and older.